Sustainability & P ESG Report

Overview

The report describes Ascendis Pharma's 2023 sustainability performance across Patients, Environmental, Social and Governance. Patient highlights include launching compassionate and expanded access programs and enrolling first patients, while the company initiated Scope 1 and 2 emissions data collection. The group-level headcount reached 879 employees, and the Board reviewed, updated and approved the Code of Business Conduct & Ethics.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Language: English
Pages
File size
Restatement: Disclosed

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services